Literature DB >> 28885616

MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cells.

Gomaa Sulaiman1,2, Aoife Cooke1,2, Brendan Ffrench1,2, Claudia Gasch1,2, Olayemi Azeez Abdullai1,2, Kevin O'Connor1,2, Salah Elbaruni1,2, Gordon Blackshields1, Cathy Spillane1,2, Helen Keegan1,2, Victoria McEneaney1,2, Ronan Knittel1,2, Annamarie Rogers3, Ian B Jeffery4, Brendan Doyle1,2, Mark Bates1, Charles d'Adhemar1,2, Mathia Yc Lee5, Eric L Campbell6, Paul N Moynagh7,6, Desmond G Higgins8, Sharon O'Toole1,9, Luke O'Neill10, John J O'Leary1,2, Michael F Gallagher1,2.   

Abstract

We have previously reported that myeloid differentiation primary response gene 88 (MyD88) is downregulated during all-trans retinoic acid (RA)-induced differentiation of pluripotent NTera2 human embryonal carcinoma cells (hECCs), whereas its maintained expression is associated with RA differentiation resistance in nullipotent 2102Ep hECCs. MyD88 is the main adapter for toll-like receptor (TLR) signalling, where it determines the secretion of chemokines and cytokines in response to pathogens. In this study, we report that loss of MyD88 is essential for RA-facilitated differentiation of hECCs. Functional analysis using a specific MyD88 peptide inhibitor (PepInh) demonstrated that high MyD88 expression in the self-renewal state inhibits the expression of a specific set of HOX genes. In NTera2 cells, MyD88 is downregulated during RA-induced differentiation, a mechanism that could be broadly replicated by MyD88 PepInh treatment of 2102Ep cells. Notably, MyD88 inhibition transitioned 2102Ep cells into a stable, self-renewing state that appears to be primed for differentiation upon addition of RA. At a molecular level, MyD88 inhibition combined with RA treatment upregulated HOX, RA signalling and TLR signalling genes. These events permit differentiation through a standard downregulation of Oct4-Sox2-Nanog mechanism. In line with its role in regulating secretion of specific proteins, conditioned media experiments demonstrated that differentiated (MyD88 low) NTera2 cell media was sufficient to differentiate NTera2 cells. Protein array analysis indicated that this was owing to secretion of factors known to regulate angiogenesis, neurogenesis and all three branches of TGF-β Superfamily signalling. Collectively, these data offer new insights into RA controlled differentiation of pluripotent cells, with notable parallels to the ground state model of embryonic stem cell self-renewal. These data may provide insights to facilitate improved differentiation protocols for regenerative medicine and differentiation-therapies in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28885616      PMCID: PMC5635222          DOI: 10.1038/cdd.2017.124

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  47 in total

Review 1.  The regulation of Hox gene expression during animal development.

Authors:  Moisés Mallo; Claudio R Alonso
Journal:  Development       Date:  2013-10       Impact factor: 6.868

2.  Targeted proteomics of the secretory pathway reveals the secretome of mouse embryonic fibroblasts and human embryonic stem cells.

Authors:  Prasenjit Sarkar; Shan M Randall; David C Muddiman; Balaji M Rao
Journal:  Mol Cell Proteomics       Date:  2012-09-15       Impact factor: 5.911

Review 3.  Discovering pluripotency: 30 years of mouse embryonic stem cells.

Authors:  Martin Evans
Journal:  Nat Rev Mol Cell Biol       Date:  2011-09-23       Impact factor: 94.444

4.  Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells.

Authors:  Ying Guo; Barbara Graham-Evans; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2005-12-08       Impact factor: 6.277

Review 5.  Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin.

Authors:  P W Andrews; M M Matin; A R Bahrami; I Damjanov; P Gokhale; J S Draper
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

6.  Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2.

Authors:  Tadaatsu Imaizumi; Satoko Aratani; Toshihiro Nakajima; Mary Carlson; Tomoh Matsumiya; Kunikazu Tanji; Keizou Ookawa; Hidemi Yoshida; Shigeki Tsuchida; Thomas M McIntyre; Stephen M Prescott; Guy A Zimmerman; Kei Satoh
Journal:  Biochem Biophys Res Commun       Date:  2002-03-22       Impact factor: 3.575

Review 7.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

8.  Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Authors:  Michael F Gallagher; Richard J Flavin; Salah A Elbaruni; Jamie K McInerney; Paul C Smyth; Yvonne M Salley; Sebastian F Vencken; Sharon A O'Toole; Alexandros Laios; Mathia Yc Lee; Karen Denning; Jinghuan Li; Sinead T Aherne; Kai Q Lao; Cara M Martin; Orla M Sheils; John J O'Leary
Journal:  J Ovarian Res       Date:  2009-12-16       Impact factor: 4.234

9.  Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass.

Authors:  Ge Guo; Ferdinand von Meyenn; Fatima Santos; Yaoyao Chen; Wolf Reik; Paul Bertone; Austin Smith; Jennifer Nichols
Journal:  Stem Cell Reports       Date:  2016-03-03       Impact factor: 7.765

10.  Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration.

Authors:  Mikaël M Martino; Kenta Maruyama; Gisela A Kuhn; Takashi Satoh; Osamu Takeuchi; Ralph Müller; Shizuo Akira
Journal:  Nat Commun       Date:  2016-03-22       Impact factor: 14.919

View more
  1 in total

Review 1.  Role of OCT4 in cancer stem-like cells and chemotherapy resistance.

Authors:  Ismail S Mohiuddin; Sung-Jen Wei; Min H Kang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-21       Impact factor: 5.187

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.